ADMA Biologics, Inc.ADMANASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+21.0%
5Y CAGR+21.5%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+21.0%/yr
vs +23.6%/yr prior
5Y CAGR
+21.5%/yr
Consistent
Acceleration
-2.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.6x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $92.85M | +25.3% |
| 2024 | $74.12M | +25.6% |
| 2023 | $59.02M | +12.5% |
| 2022 | $52.46M | +22.3% |
| 2021 | $42.90M | +22.4% |
| 2020 | $35.05M | +35.3% |
| 2019 | $25.91M | +15.1% |
| 2018 | $22.50M | +24.4% |
| 2017 | $18.09M | +113.0% |
| 2016 | $8.49M | - |